Literature DB >> 11734481

Tuberculum intercondylare tibiae tertium as a predictive factor for anterior cruciate ligament injury.

M Pećina1, I Bajok, H I Pećina.   

Abstract

The aim of this study was to assess the presence of tuberculum intercondylare tibiae tertium, also known as Parsons' knob, and to determine its prominence. Knee radiographs of 171 patients operated on for anterior cruciate ligament injury were examined. The control group included 120 sex- and age-matched patients who underwent orthopaedic examination for knee pain, in whom anterior cruciate ligament injury was ruled out. Knee radiographs revealed the presence of tuberculum intercondylare tibiae tertium in 55 (32.2%) and 16 (13.3%) patients from the study and control groups, respectively. The between-group difference was statistically significant. The authors developed their own method of tuberculum intercondylare tibiae tertium measurement using proportional coefficients based on the length of the tibial plateau to compare the values of the tuberculum intercondylare tibiae tertium. The results showed tuberculum intercondylare tibiae tertium to be not only more common but also more pronounced, especially in height, in the patients with anterior cruciate ligament lesions.

Entities:  

Mesh:

Year:  2001        PMID: 11734481     DOI: 10.1177/03635465010290060601

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  2 in total

1.  The relationship between graft intensity on MRI and tibial tunnel placement in anatomical double-bundle ACL reconstruction.

Authors:  Takanori Teraoka; Yusuke Hashimoto; Shinji Takahashi; Shinya Yamasaki; Yohei Nishida; Hiroaki Nakamura
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-07-31

2.  Risk factors for anterior cruciate ligament injury: assessment of tibial plateau anatomic variables on conventional MRI using a new combined method.

Authors:  Mohammad Shahnawaz Khan; Jong Keun Seon; Eun Kyoo Song
Journal:  Int Orthop       Date:  2011-02-22       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.